Related Experiment Video
Updated: Jul 19, 2026

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells
Published on: March 28, 2013
Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis
Laura Piqueras1, Andrew R Reynolds, Kairbaan M Hodivala-Dilke
1Cardiac, Vascular & Inflammation Research, William Harvey Research Institute, Barts and the London, Queen Mary University London, Charterhouse Sq, London EC1M 6BQ, UK.
Objective:
The role of the nuclear receptor peroxisome-proliferator activated receptor (PPAR)-beta/delta in endothelial cells remains unclear. Interestingly, the selective PPARbeta/delta ligand GW501516 is in phase II clinical trials for dyslipidemia. Here, using GW501516, we have assessed the involvement of PPARbeta/delta in endothelial cell proliferation and angiogenesis.
Methods And Results:
Western blot analysis indicated PPARbeta/delta was expressed in primary human umbilical and aortic endothelial cells, and in the endothelial cell line, EAHy926. Treatment with GW501516 increased human endothelial cell proliferation and morphogenesis in cultures in vitro, endothelial cell outgrowth from murine aortic vessels in vitro, and angiogenesis in a murine matrigel plug assay in vivo. GW501516 induced vascular endothelial cell growth factor mRNA and peptide release, as well as adipose differentiation-related protein (ADRP), a PPARbeta/delta target gene. GW501516-induced proliferation, morphogenesis, vascular endothelial growth factor (VEGF), and ADRP were absent in endothelial cells transfected with dominant-negative PPARbeta/delta. Furthermore, treatment of cells with cyclo-VEGFI, a VEGF receptor1/2 antagonist, abolished GW501516-induced endothelial cell proliferation and tube formation.
Conclusions:
PPARbeta/delta is a novel regulator of endothelial cell proliferation and angiogenesis through VEGF. The use of GW501516 to treat dyslipidemia may need to be carefully monitored in patients susceptible to angiogenic disorders.
Insights
Peroxisome-proliferator activated receptor (PPAR)-beta/delta activation promotes endothelial cell proliferation and angiogenesis. This pathway, involving vascular endothelial growth factor (VEGF), highlights potential risks for GW501516 in dyslipidemia patients prone to angiogenic disorders.
Area of Science:
- Endocrinology
- Molecular Biology
- Cell Biology
Background:
- The function of the nuclear receptor peroxisome-proliferator activated receptor (PPAR)-beta/delta in endothelial cells is not well understood.
- The selective PPARbeta/delta ligand GW501516 is currently undergoing clinical trials for dyslipidemia treatment.
Purpose of the Study:
- To investigate the role of PPARbeta/delta in endothelial cell proliferation and angiogenesis using the selective ligand GW501516.
- To determine the molecular mechanisms underlying PPARbeta/delta-mediated effects on endothelial cells.
Main Methods:
- Western blot analysis to confirm PPARbeta/delta expression in human and murine endothelial cells.
- In vitro assays measuring endothelial cell proliferation, morphogenesis, and outgrowth.
- In vivo matrigel plug assay to assess angiogenesis.
- Analysis of vascular endothelial cell growth factor (VEGF) and adipose differentiation-related protein (ADRP) expression.
- Experiments using dominant-negative PPARbeta/delta and VEGF receptor antagonists.
Main Results:
- PPARbeta/delta was expressed in various endothelial cell types.
- GW501516 significantly enhanced endothelial cell proliferation, morphogenesis, and in vivo angiogenesis.
- GW501516 upregulated VEGF and ADRP expression.
- Inhibition of PPARbeta/delta or VEGF signaling abolished GW501516-induced effects.
- GW501516 treatment increased endothelial cell outgrowth and tube formation.
Conclusions:
- PPARbeta/delta acts as a novel regulator of endothelial cell proliferation and angiogenesis, primarily mediated through VEGF.
- The therapeutic use of GW501516 for dyslipidemia warrants caution in patients at risk for angiogenic disorders due to its pro-angiogenic effects.
More Related Videos
05:30Trophoblast Cell Recovery from Angiogenesis-Tube Formation Assay for Differentiation Marker Expression Analysis
Published on: November 8, 2024
07:15Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Related Concept Videos
Regulation of Angiogenesis and Blood Supply
TGF - β Signaling Pathway
PI3K/mTOR/AKT Signaling Pathway
Cell Specific Gene Expression
Mechanism of Angiogenesis
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...